Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...
AMDA’s new COVID vaccine PowerPoint can help answer resident, staff concerns
By
Alicia Lasek
Dec 09, 2020
A toolkit created by industry clinicians aims to help long-term care operators address questions about getting vaccinated. A PowerPoint presentation is available to share with staff and residents.
New NIH network to recruit thousands for late-stage COVID-19 vaccine trials
By
Alicia Lasek
Jul 09, 2020
A nationwide clinical trial network will test promising COVID-19 vaccines and antibodies. There are five possible vaccine candidates.
COVID-19, flu shots down in healthcare workers, studies find
By
Kristen Fischer
Nov 13, 2023
Healthcare workers were more apt to get the flu shot than the COVID-19 vaccine this year. Hospital workers specifically, meanwhile, were less likely to get the flu shot after the pandemic rather than before...
22 percent of those over 50 hospitalized with RSV had acute cardiac events: study
By
Kristen Fischer
Apr 16, 2024
About a quarter of people over the age of 50 with respiratory syncytial virus (RSV) experienced acute cardiac events, according to a new study. Furthermore, the risk for severe outcomes in those who had...
Protection declines dramatically over time for all three COVID-19 vaccines: study
By
Amy Novotney
Nov 08, 2021
As the delta variant became the dominant strain of coronavirus across the United States, all three COVID-19 vaccines available to Americans lost some of their protective power, with vaccine efficacy among...
CDC: More nursing homes now can obtain, provide single-dose COVID vaccines
By
Alicia Lasek
Dec 20, 2022
Nursing homes that are not already enrolled as full providers in the CDC’s COVID-19 Vaccination Program now can apply to provide shots directly to residents and staff.
J&J vaccine effective against COVID Delta variant, drugmaker says
By
Alicia Lasek
Jul 06, 2021
Johnson & Johnson’s single-shot COVID-19 vaccine prompts a “strong neutralizing antibody response” that lasts at least eight months, the drugmaker has announced.
No severe reactions to COVID-19 vaccine so far in long-term care: early reports
By
Alicia Lasek
Jan 04, 2021
The initial onsite clinic experience was positive overall, despite some expected side effects, says industry advocate LeadingAge, whose affiliates represent 43 states.
COVID trial vaccines may be inadequate, some FDA advisors fear
By
Alicia Lasek
Oct 26, 2020
The current vaccine trials may be too focused on mild rather than severe disease, some advisors contend. But their arguments got pushback in a meeting streamed on the agency’s YouTube channel.